Abstract: Described herein are medical fluid infusion systems for pumping a fluid to a patient, such as in a hospital environment. In one aspect, disclosed is an infusion system including a drive assembly having a drive fluid reservoir and a drive mechanism configured to apply a force to drive fluid from the drive fluid reservoir through a length of tubing. The infusion system includes a hydraulic assembly having a first fluid chamber having an inlet port configured to be in fluid communication with the length of tubing and a second fluid chamber having an outlet port configured to be in fluid communication with a patient extension set and a flexible movable divider sealing the first fluid chamber from the second fluid chamber. Related apparatus, systems, techniques and articles are also described.

Abstract: An inspectable joint in a medical device is disclosed that includes at least one medical-grade tube having an end, a medical-grade fitting having at least one joining surface configured to accept the end of the tube, and a joining material disposed between the tube and the joining surface. The joining material includes a first component configured to couple the tube to the fitting and a second component configured to provide observable evidence of the presence of the joining material between the tube and the joining surface.

Abstract: A pumping segment having a low shut-off force is disclosed. The pumping segment includes a tube having an interior surface with at least two notches on opposite sides of the interior surface.

Abstract: An inspectable joint in a medical device is disclosed that includes at least one medical-grade tube having an end, a medical-grade fitting having at least one joining surface configured to accept the end of the tube, and a joining material disposed between the tube and the joining surface. The joining material includes a first component configured to couple the tube to the fitting and a second component configured to provide observable evidence of the presence of the joining material between the tube and the joining surface.

Abstract: The present invention provides compositions and their use in diagnosing ulcerative colitis, Crohn's Disease, and inflammatory bowel disease.

Abstract: The present invention provides novel compositions and their use in classifying breast tumors.

Abstract: The present invention provides novel compositions and their use in classifying acute myelogenous leukemia.

Abstract: The present invention provides novel compositions and their use in classifying gliomas. In a preferred embodiment, the methods are used to discriminate between oligodendroglioma and glioblastoma.

Abstract: The present invention provides novel compositions and their use in classifying acute myelogenous leukemia.

Abstract: The present invention provides novel compositions and their use in classifying gliomas. In a preferred embodiment, the methods are used to discriminate between oligodendroglioma and glioblastoma.

Abstract: Dioxaborines as organic n-semiconductors, a process for the production of semiconductors utilizing dioxaborines, and a semiconductor component, a field effect transistor, and a diode having a dioxaborine are provided. Dioxaborines have a conjugated ?-system that carries two terminal six-membered dioxaborine heterocycles that are electronically linked to one another via the central ?-system. The compounds have good electron mobility and very good reversibility of redox behavior and are therefore suitable as organic semiconductors in electronic semiconductor components. Processes for manufacturing the electronic semiconductor components utilize the dioxabroines.

Abstract: The present invention provides novel compositions and their use in classifying acute myelogenous leukemia.

Abstract: The present invention provides unique sequence probes, methods for generating them, and methods for using unique sequence probes in hybridization assays.

Abstract: The present invention provides improved methods for in situ hybridization (ISH) comprising: (a) obtaining a tissue sample from a subject; (b) contacting the tissue sample with a fixative under conditions to cause fixation of the tissue sample; (c) contacting nucleic acids in the tissue sample with a detectable probe under conditions suitable to promote hybridization of the detectable probe to a target RNA in the tissue sample; (d) removing non-bound probe from the tissue sample; and (e) detecting the probe bound to the target RNA.

Abstract: The present invention provides novel compositions and their use in classifying breast tumors.

Abstract: The present invention provides novel compositions and their use in classifying gliomas. In a preferred embodiment, the methods are used to discriminate between oligodendroglioma and glioblastoma.

Abstract: The present invention provides novel methods for in situ hybridization in the absence of competitor DNA.

Abstract: Dioxaborines as organic n-semiconductors, a process for the production of semiconductors utilizing dioxaborines, and a semiconductor component, a field effect transistor, and a diode having a dioxaborine are provided. Dioxaborines have a conjugated &pgr;-system that carries two terminal six-membered dioxaborine heterocycles that are electronically linked to one another via the central &pgr;-system. The compounds have good electron mobility and very good reversibility of redox behavior and are therefore suitable as organic semiconductors in electronic semiconductor components. Processes for manufacturing the electronic semiconductor components utilize the dioxabroines.

Abstract: An antenna for use with a cellular telephone includes a conductive wire having a binder disposed thereover. The conductive wire may be entirely shaped in the form of a coil or only partially shaped like a coil. The binder is preferably a polymeric material which is clear and transparent. The binder includes a quartz crystal powder, reflective flecks such as mylar, and a fluorescent dye dispersed therein. The binder is applied over the conductive wire and reduces emissions of electromagnetic radiation.

Abstract: An antenna for use with a cellular telephone includes a conductive wire having a binder disposed thereover. The conductive wire may be entirely shaped in the form of a coil or only partially shaped like a coil. The binder is preferably a polymeric material which is clear and transparent. The binder includes a quartz crystal powder, reflective flecks such as mylar, and a fluorescent dye dispersed therein. The binder is applied over the conductive wire and reduces emissions of electromagnetic radiation.